JP2022550203A5 - - Google Patents

Info

Publication number
JP2022550203A5
JP2022550203A5 JP2022520195A JP2022520195A JP2022550203A5 JP 2022550203 A5 JP2022550203 A5 JP 2022550203A5 JP 2022520195 A JP2022520195 A JP 2022520195A JP 2022520195 A JP2022520195 A JP 2022520195A JP 2022550203 A5 JP2022550203 A5 JP 2022550203A5
Authority
JP
Japan
Prior art keywords
pyrrolo
isopropyl
thiazole
pyridine
triazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022520195A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022550203A (ja
JP7629007B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/053358 external-priority patent/WO2021067326A1/en
Publication of JP2022550203A publication Critical patent/JP2022550203A/ja
Publication of JP2022550203A5 publication Critical patent/JP2022550203A5/ja
Application granted granted Critical
Publication of JP7629007B2 publication Critical patent/JP7629007B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022520195A 2019-10-01 2020-09-30 置換二環ヘテロアリール化合物 Active JP7629007B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962908840P 2019-10-01 2019-10-01
US62/908,840 2019-10-01
PCT/US2020/053358 WO2021067326A1 (en) 2019-10-01 2020-09-30 Substituted bicyclic heteroaryl compounds

Publications (3)

Publication Number Publication Date
JP2022550203A JP2022550203A (ja) 2022-11-30
JP2022550203A5 true JP2022550203A5 (enExample) 2023-09-28
JP7629007B2 JP7629007B2 (ja) 2025-02-12

Family

ID=72896115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520195A Active JP7629007B2 (ja) 2019-10-01 2020-09-30 置換二環ヘテロアリール化合物

Country Status (6)

Country Link
US (1) US12448395B2 (enExample)
EP (1) EP4041730A1 (enExample)
JP (1) JP7629007B2 (enExample)
KR (1) KR20220075381A (enExample)
CN (1) CN114761404B (enExample)
WO (1) WO2021067326A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116783202A (zh) * 2021-02-09 2023-09-19 吉利德科学公司 噻吩并吡咯化合物
ES3054393T3 (en) * 2021-02-09 2026-02-03 Gilead Sciences Inc Thienopyrrole compounds
KR20230171469A (ko) 2021-04-16 2023-12-20 길리애드 사이언시즈, 인코포레이티드 티에노피롤 화합물
EP4398989A1 (en) * 2021-09-10 2024-07-17 Gilead Sciences, Inc. Thienopyrrole compounds
WO2026002036A1 (zh) * 2024-06-26 2026-01-02 北京双鹤润创科技有限公司 一种化合物及其用途

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
HUP0104987A3 (en) 1998-12-18 2002-09-30 Axys Pharmaceuticals Inc South Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
CA2387351C (en) 1999-10-19 2009-09-08 Merck & Co., Inc. Indole derivatives as tyrosine kinase inhibitors
DK1474425T3 (da) 2002-01-07 2006-09-25 Eisai Co Ltd Deazapuriner og anvendelser deraf
FR2836915B1 (fr) 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
MXPA05013922A (es) 2003-06-20 2006-02-24 Coley Pharm Group Inc Antagonistas de receptor tipo toll de molecula pequena.
WO2007115306A2 (en) 2006-04-04 2007-10-11 Myriad Genetics, Inc. Compounds for diseases and disorders
US20060235037A1 (en) 2005-04-15 2006-10-19 Purandare Ashok V Heterocyclic inhibitors of protein arginine methyl transferases
DK1899333T3 (da) 2005-06-27 2009-06-15 Sanofi Aventis Pyrazolopyridinderivater som inhibitorer af beta-adrenerg receptor-kinase 1
DE102006033109A1 (de) 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
US8027888B2 (en) 2006-08-31 2011-09-27 Experian Interactive Innovation Center, Llc Online credit card prescreen systems and methods
WO2008065198A1 (en) 2006-12-01 2008-06-05 Galapagos N.V. Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases
WO2008152471A1 (en) 2007-06-12 2008-12-18 Coley Pharmaceutical Group, Inc. Quinazoline derivative useful as toll-like receptor antagonist
WO2009030996A1 (en) 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Triazole compounds as toll-like receptor (tlr) agonists
EP2205085A1 (en) 2007-09-25 2010-07-14 Merck Sharp & Dohme Corp. 2-aryl or heteroaryl indole derivatives
US8354400B2 (en) 2008-09-26 2013-01-15 Eisai R&D Co., Ltd. Benzoxazole compounds and methods of use
CA2738929A1 (en) 2008-10-17 2010-04-22 Boehringer Ingelheim International Gmbh Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
TWI462920B (zh) 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
NO2453895T3 (enExample) 2009-07-16 2018-10-20
BR112012006630A2 (pt) 2009-09-24 2016-05-03 Hoffmann La Roche derivados em indol como moduladores dos canais de cálcio ativados para liberação de cálcio (crac)
US20110098311A1 (en) 2009-10-22 2011-04-28 Vertex Pharmaceuticals Incorported Compositions for treatment of cystic fibrosis and other chronic diseases
DE102009058280A1 (de) * 2009-12-14 2011-06-16 Merck Patent Gmbh Thiazolderivate
WO2012054862A2 (en) 2010-10-21 2012-04-26 The Brigham And Women's Hospital, Inc. Agents, compositions, and methods for treating pruritis and related skin conditions
DK2663555T3 (en) 2011-01-12 2017-03-27 Ventirx Pharmaceuticals Inc SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
EP3208263A1 (en) 2011-01-12 2017-08-23 VentiRx Pharmaceuticals, Inc. Substituted benzoazepines as toll-like receptor modulators
WO2012167053A1 (en) 2011-06-01 2012-12-06 Janus Biotherapeutics, Inc. Novel immune system modulators
CA2837227C (en) 2011-06-01 2022-05-10 Janus Biotherapeutics, Inc. Novel immune system modulators
CA2836487A1 (en) 2011-06-09 2012-12-13 Rhizen Pharmaceuticals Sa Novel compounds as modulators of gpr-119
TWI567079B (zh) 2011-07-15 2017-01-21 健生醫藥公司 作為伽瑪分泌酶調節劑之新穎的經取代的吲哚衍生物
CA2850932A1 (en) 2011-10-04 2013-04-11 Janus Biotherapeutics, Inc. Novel imidazole quinoline-based immune system modulators
JP6184423B2 (ja) 2012-05-18 2017-08-23 大日本住友製薬株式会社 カルボン酸化合物
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
WO2014025114A1 (ko) 2012-08-10 2014-02-13 주식회사 두산 유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자
EP2738172A1 (en) 2012-11-28 2014-06-04 Almirall, S.A. New bicyclic compounds as crac channel modulators
SG10202103278TA (en) 2013-10-14 2021-04-29 Eisai R&D Man Co Ltd Selectively substituted quinoline compounds
EP3080124A1 (en) 2013-12-13 2016-10-19 Takeda Pharmaceutical Company Limited Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors
HRP20210927T1 (hr) 2014-08-15 2021-09-03 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Spojevi pirolopirimidina koje se koriste kao agonist tlr7
EP3183251A4 (en) 2014-08-22 2017-12-27 Janus Biotherapeutics, Inc. Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
KR20190040140A (ko) * 2016-05-25 2019-04-17 아카나 테라퓨틱스, 엘티디. 질환의 치료를 위한 융합된 비시클릭 화합물
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
MX391344B (es) 2016-07-30 2025-03-21 Bristol Myers Squibb Co Compuestos indol sustituidos con dimetoxifenilo como inhibidores de receptores tipo toll 7, 8 o 9 (tlr7, tlr8 o tlr9).
KR102519535B1 (ko) 2016-09-09 2023-04-06 브리스톨-마이어스 스큅 컴퍼니 피리딜 치환된 인돌 화합물
FI3728252T3 (fi) * 2017-12-18 2023-10-18 Bristol Myers Squibb Co 4-atsaindoliyhdisteitä
CA3085942A1 (en) 2017-12-20 2019-06-27 Bristol-Myers Squibb Company Aryl and heteroaryl substituted indole compounds
TW202132316A (zh) * 2019-11-04 2021-09-01 美商銳新醫藥公司 Ras抑制劑
IL322454A (en) * 2019-11-04 2025-09-01 Revolution Medicines Inc ras inhibitors
US20250195521A1 (en) * 2020-09-03 2025-06-19 Revolution Medicines, Inc. Use of sos1 inhibitors to treat malignancies with shp2 mutations
CA3194067A1 (en) * 2020-09-15 2022-03-24 Revolution Medicines, Inc. Ras inhibitors

Similar Documents

Publication Publication Date Title
JP2022550203A5 (enExample)
JP2021506858A5 (enExample)
KR101440634B1 (ko) 글루코키나제 활성제로서의 2-아미노피리딘 유사체
JP2021506889A5 (enExample)
AU2011234398C1 (en) Novel NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
HRP20200962T1 (hr) Novi spojevi
US9637491B2 (en) Pyrazolo[4,3-D]pyrimidines as kinase inhibitors
JP2023501956A5 (enExample)
ES2485913T3 (es) Compuestos novedosos útiles para el tratamiento de enfermedades degenerativas e inflamatorias
US8148380B2 (en) Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
RU2013120966A (ru) ФУРО[3,2-d]ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ
EP2300466B1 (en) Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
JP2016523911A5 (enExample)
JP2019535664A5 (enExample)
JP2021507912A5 (enExample)
US20260015358A1 (en) Bicyclic derivatives, compositions and uses thereof
PH12014502041B1 (en) Heterocyclyl compounds as mek inhibitors
JP2014511885A5 (enExample)
CA2672737A1 (en) Anti-viral compounds
US20170008899A1 (en) Btk inhibitors
US20110098296A1 (en) Thiazole And Oxazole Kinase Inhibitors
CN101405278A (zh) 新颖的杂环NF-κB抑制剂
NZ577491A (en) 2-heteroaryl-3-hydroxy-4-oxo-pyrido[1,2-a]pyrimidines and uses thereof
WO2007084728A2 (en) 2-imino-benzimidazoles
AU2009254928A1 (en) Thiazolo [5, 4-B] pyridine and oxazolo [5, 4-B] pyridine derivatives as antibacterial agents